C2N Clearance Header (IMAGE)

Washington University in St. Louis

C2N Clearance Header

Caption

The FDA has cleared a blood test developed from technology invented at WashU Medicine to aid in diagnosing Alzheimer’s disease. The test, PrecivityAD2, can detect amyloid plaque biomarkers with over 90% accuracy, offering a less invasive alternative to spinal taps and brain scans.

Credit

Matt Miller/WashU Medicine

Usage Restrictions

This image is to be used in accordance with the mission, policies and guidelines of WashU Medicine. Visit https://wustl.edu/about/compliance-policies/media-policies/multimedia-use/ for more information.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.